Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability
暂无分享,去创建一个
F. Lévi | S. Giacchetti | P. Innominato | C. Guettier | R. Adam | M. Bouchahda | A. Karaboué | R. Saffroy | L. Gorden | D. Hauteville